Dupin S, Tafani J A, Mazarguil H, Zajac J M
Laboratoire de Pharmacologie et de Toxicologie Fondamentales, CNRS, Toulouse, France.
Peptides. 1991 Jul-Aug;12(4):825-30. doi: 10.1016/0196-9781(91)90141-b.
The selective delta opioid agonist [D-Ala2]deltorphin-I was radioiodinated and the product purified using reverse phase HPLC. The binding characteristics and distribution profile of [125I][D-Ala2]deltorphin-I were assessed in mouse brain using homogenate binding techniques and quantitative autoradiography. [125I][D-Ala2]deltorphin-I bound with high affinity to a single class of sites (KD = 0.5 nM) in brain membrane preparations and striatal sections. Competition studies indicated that [125I][D-Ala2]deltorphin-I was selectively labeling delta opioid receptors as shown by the ratio of apparent affinities for mu and delta receptors (KI mu/KI delta = 1388). The autoradiographical distribution profile of [125I][D-Ala2]deltorphin-I binding sites was also consistent with that of other delta-selective radioligands. The data indicate that [125I][D-Ala2]deltorphin-I binds to delta opioid receptors with high affinity and selectivity. Because of its very high specific activity, it can be detected rapidly with high sensitivity by autoradiographic emulsion.
将选择性δ阿片样物质激动剂[D - Ala2]强啡肽 - I进行放射性碘化,并使用反相高效液相色谱法纯化产物。利用匀浆结合技术和定量放射自显影法在小鼠脑中评估[125I][D - Ala2]强啡肽 - I的结合特性和分布情况。[125I][D - Ala2]强啡肽 - I与脑膜制剂和纹状体切片中的单一类位点(KD = 0.5 nM)具有高亲和力结合。竞争研究表明,[125I][D - Ala2]强啡肽 - I选择性地标记δ阿片样物质受体,μ和δ受体的表观亲和力之比(KIμ/KIδ = 1388)表明了这一点。[125I][D - Ala2]强啡肽 - I结合位点的放射自显影分布情况也与其他δ选择性放射性配体的情况一致。数据表明,[125I][D - Ala2]强啡肽 - I以高亲和力和选择性与δ阿片样物质受体结合。由于其非常高的比活性,通过放射自显影乳剂可以快速且高灵敏度地检测到它。